Pharmacists across continents report a sharp escalation in medicine prices, with common painkillers in some regions quadrupling in cost since the United States and Israel began their war with Iran. This surge directly impacts household budgets and global health programs, according to industry leaders like Goh Miah Kiat, CEO of Karex, the world's largest condom producer. His company's vital shipments of contraceptives remain stranded at sea, unable to reach destinations in Europe and the United States.
Initially, the global economy fixated on the conflict's immediate toll on oil, gas, and fertilizer supplies. Iran’s swift decision to block the Strait of Hormuz, a critical maritime passage for 20 percent of the world’s oil and liquefied natural gas, instantly reshaped energy markets. However, as weeks turned into months, the ripple effects spread further, now reaching the medicine cabinets of ordinary families, from London to Mumbai.
This wider impact reveals the intricate web connecting geopolitical tensions to everyday necessities. Prices for essential over-the-counter medicines in the United Kingdom have climbed by 20 to 30 percent. The common painkiller paracetamol, for example, has seen its wholesale price jump by 41 pence (55 cents) to 1.99 pounds ($2.69) for a pack of 100 500mg tablets by late March, as reported by Olivier Picard, chair of the National Pharmacy Association.
While that particular price eased slightly to 1.09 pounds ($1.47) soon after, the initial spike caused widespread concern. In India, chemists report even steeper increases. A former board member of the Visakha Chemists Association told the country’s Economic Times on April 17 that common painkillers like paracetamol are rising by approximately 96 percent.
Beyond painkillers, contraceptives also face significant price hikes. Goh Miah Kiat, CEO of Karex, stated on Tuesday that his company would need to raise prices by 20 to 30 percent. His firm produces more than 5 billion condoms annually, supplying major brands like Durex and Trojan, alongside global aid initiatives run by the United Nations. "The situation is definitely very fragile, prices are expensive," Miah Kiat told the Reuters news agency. "We have no choice but to transfer the costs right now to the customers." His ships, laden with vital supplies, are still at sea, unable to complete their journeys to the West. "We’re seeing a lot more condoms actually sitting on vessels that have not arrived at their destination but are highly required," he added, noting that many developing countries lack sufficient stock.
The underlying cause traces back to the Strait of Hormuz blockage, which has disrupted global supply chains far beyond oil. "Pharmaceuticals are tied to both petrochemical feedstocks, a large part of which are sourced through the Persian Gulf," explained Frederic Schneider, a nonresident senior fellow at the Middle East Council on Global Affairs, to Al Jazeera. These chemical building blocks are vital. Additionally, logistics routes connecting East Asia and Europe, particularly for pharmaceuticals, rely on transhipment hubs in the Gulf, like Dubai.
Many medicines require special handling, including an unbroken cold chain. Both aspects have suffered disruption due to the conflict. Air logistics present another layer of vulnerability for the pharmaceutical sector.
Wouter Dewulf, a professor at the University of Antwerp in Belgium and an expert in pharma logistics, points out that 35 percent of pharmaceuticals travel by air. For critical or life-saving medicines and vaccines, this figure climbs to about 90 percent. "I estimate that 22 percent of global air cargo flows are exposed to Middle East disruptions," Dewulf stated. The immediate global effect, he noted, is delays, rerouting, and higher costs, rather than a physical worldwide shortage of medicines.
Generic medicines, with their typically thinner profit margins, are experiencing a higher relative price increase due to rising air cargo fares, especially on East-West corridors. What this actually means for your family is that basic health needs become more expensive. A common headache remedy, a fever reducer for a child, or essential family planning supplies – these are not luxuries.
They are fundamental items. When their prices climb by 20 percent, 96 percent, or even quadruple, working families absorb that cost. For those already struggling, these increases can force impossible choices between medicine and other necessities.
The former board member of the Visakha Chemists Association in India attributed the rise in paracetamol prices to a spike in raw materials. He cautioned that prices for the drug could increase by another 30 to 40 percent, deepening the financial strain on households. The policy says one thing – that global trade routes are resilient and markets will adjust.
The reality says another. Cargoes of essential medical supplies are adrift, and the most vulnerable populations face the harshest consequences. This disparity highlights how quickly geopolitical instability can undermine the economic stability of ordinary people.
While some countries possess domestic hydrocarbon and petrochemical supplies, like the United States, or can source from alternative locations, like China, others are far more exposed. India, a major producer of pharmaceuticals, depends heavily on supplies from the Gulf, making it a critical chokepoint in the global pharmaceutical network, Frederic Schneider observed. Strategic stockpiling also plays a significant role in mitigating immediate impact.
The European Union, for example, maintains a “solidarity mechanism,” a recent strategy that includes pharmaceuticals, alongside country-specific stockpiling requirements that range from two to ten months’ worth of medicines. This provides a buffer. However, even some Global North countries, such as the NHS in the UK, are sounding alarm bells and warning of potential shortages in the coming weeks.
The problem is far more acute for Global South countries, particularly sub-Saharan Africa, which often lack significant stockpiles. These nations also possess insufficient financial capacity to absorb the price increases resulting from the supply crunch. Countries currently experiencing humanitarian crises, such as Sudan, Yemen, and Palestine, face an even more precarious situation.
While governments in the Gulf Cooperation Council (GCC) assure their populations of secure supplies, this stability could shift if the conflict intensifies. Wouter Dewulf emphasized that the real exposure lies in countries directly affected by the conflict and regional disruption, naming Lebanon, Palestine, and Iran. He also identified a second group: fragile, aid-dependent countries that were already under severe pressure before the war began.
A third risk group includes import-dependent Gulf markets, especially for cold-chain medicines and cancer treatments. These flows were rerouted when major hubs like Dubai, Abu Dhabi, and Doha experienced air strikes. In the broader Middle East, the situation remains more manageable than in the immediate conflict zones, with risks and delays present, but not yet a generalized collapse, especially as airlift operations gradually resume, prioritizing pharmaceutical shipments due to their higher yield.
Why It Matters: This escalating crisis in pharmaceutical supply chains is not just about numbers on a spreadsheet; it is about access to basic healthcare for millions. From preventing disease with contraceptives to managing chronic pain with common drugs, the availability and affordability of medicines directly influence public health outcomes and economic stability for families. The disruption underscores the fragility of global supply networks and the disproportionate impact of geopolitical conflicts on the world’s most vulnerable populations, threatening to widen existing health inequities.
Ensuring equitable access to essential medicines during times of crisis becomes a critical test of international cooperation and preparedness. Key Takeaways: - The US-Israel war with Iran has significantly driven up global pharmaceutical prices, with some painkillers quadrupling in cost. - Blockades in the Strait of Hormuz disrupt petrochemical feedstocks and critical air/sea logistics for medicines. - Condom shipments are delayed, and prices are rising, impacting global aid programs and family planning efforts. - Vulnerable Global South nations and humanitarian crisis zones face the most severe consequences due to limited stockpiles and financial constraints. Looking ahead, the situation’s trajectory hinges on several factors.
Diplomatic efforts to de-escalate the conflict will be paramount, as will the ability of supply chain managers to find and secure alternative routes and suppliers. Companies like Karex will continue to navigate logistical challenges, potentially passing on further costs to consumers. Governments and international aid organizations must assess their strategic stockpiles and consider emergency measures to prevent critical shortages, especially in aid-dependent regions.
The world will be watching for any signs of resolution in the conflict or further strain on these vital global supply lines.
Key Takeaways
— - The US-Israel war with Iran has significantly driven up global pharmaceutical prices, with some painkillers quadrupling in cost.
— - Blockades in the Strait of Hormuz disrupt petrochemical feedstocks and critical air/sea logistics for medicines.
— - Condom shipments are delayed, and prices are rising, impacting global aid programs and family planning efforts.
— - Vulnerable Global South nations and humanitarian crisis zones face the most severe consequences due to limited stockpiles and financial constraints.
Source: Al Jazeera
